Stockscreener 앱 받기
2.06
5.10%
0.10
시간 외 거래:
2.07
0.010
+0.49%
전일 마감가:
$1.96
열려 있는:
$2
하루 거래량:
593.50K
Relative Volume:
0.43
시가총액:
$141.53M
수익:
$832.00K
순이익/손실:
$-135.12M
주가수익비율:
-0.3383
EPS:
-6.09
순현금흐름:
$-124.69M
1주 성능:
+17.05%
1개월 성능:
-20.16%
6개월 성능:
+3.00%
1년 성능:
-50.84%
1일 변동 폭
$1.97
$2.0696
1주일 범위
$1.76
$2.0696
52주 변동 폭
$1.30
$4.61
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
명칭
Inovio Pharmaceuticals Inc
전화
(858) 410-3134
주소
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
INO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.06 | 134.66M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2024-01-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-11-09 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2022-11-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-19 | 재개 | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-12-29 | 재개 | Jefferies | Hold |
| 2021-09-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-24 | 개시 | Jefferies | Hold |
| 2021-03-23 | 개시 | BofA Securities | Neutral |
| 2021-02-12 | 개시 | Oppenheimer | Outperform |
| 2020-11-17 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-11-10 | 업그레이드 | ROTH Capital | Sell → Neutral |
| 2020-09-28 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-07-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-07-01 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-06-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-21 | 개시 | The Benchmark Company | Buy |
| 2020-04-30 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-03-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | 개시 | ROTH Capital | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
| 2017-10-18 | 개시 | RBC Capital Mkts | Outperform |
| 2017-09-06 | 개시 | Citigroup | Buy |
| 2017-06-08 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | 재확인 | Maxim Group | Buy |
| 2017-03-16 | 업그레이드 | Maxim Group | Hold → Buy |
| 2017-03-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
모두보기
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
Is Inovio Pharmaceuticals Inc. (GBM) stock a top dividend aristocrat candidateJuly 2025 Movers & Weekly Momentum Stock Picks - moha.gov.vn
What Technical Resistance Could Cap Grovy India Limiteds UpsideTrading Volume Surges & Discover Strategies with Fellow Traders - earlytimes.in
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults (PR Newswire) - Aktiellt
INOVIO Maps Out High-Stakes December as Investors Eye Rare Disease Catalysts - MyChesCo
What analysts say about Inovio Pharmaceuticals Inc GBM stockStock Buyback Updates & High Return Portfolio Growth - earlytimes.in
How strong is Inovio Pharmaceuticals Inc. (GBM) stock earnings growth2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
What sentiment indicators say about Inovio Pharmaceuticals Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock gain from lower interest ratesWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
INOVIO Advances Toward First Commercial Product as BLA Filing Caps Pivotal Quarter - MyChesCo
Why Inovio Pharmaceuticals Inc. stock is favored by top institutions2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Is Inovio Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Why analysts maintain buy rating on Inovio Pharmaceuticals Inc. (GBM) stockMarket Growth Review & Weekly Return Optimization Alerts - newser.com
Published on: 2025-11-20 00:40:52 - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock survive global slowdownTrend Reversal & Low Volatility Stock Recommendations - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock attract long term capital inflows2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock inflation resilientEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe chartsDollar Strength & AI Enhanced Execution Alerts - newser.com
What is the fair value estimate for Inovio Pharmaceuticals Inc. (GBM) stock in 2025 - newser.com
Why Inovio Pharmaceuticals Inc. stock is rated strong buy2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Can machine learning forecast Inovio Pharmaceuticals Inc. recovery2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
Is Inovio Pharmaceuticals Inc. trending in predictive chart modelsRate Cut & Technical Pattern Recognition Alerts - newser.com
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthMarket Activity Recap & Verified Entry Point Signals - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsJuly 2025 Highlights & Free Verified High Yield Trade Plans - newser.com
Why Inovio Pharmaceuticals Inc. stock is a value investor pick2025 Price Momentum & Low Drawdown Investment Ideas - newser.com
Inovio Pharmaceuticals Inc (INO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
1.13%
자본화:
|
볼륨(24시간):